Blood-thinning medication linked to slower cognitive decline

People with some atrial fibrillation and Alzheimer's illness who are treated with modern NOAC blood-thinning medicines whitethorn acquisition a slower complaint of cognitive decline. This is shown by a survey from Karolinska Institutet published successful the European Heart Journal.